Journals / Journal of Clinical and Experimental Investigations / 2026 / Cilt: 5 Sayı: 1

Heparin induced thrombocytopenia

Heparine bağlı trombositopeni

Pages
137–144
Publication Date
2014-03-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

J Clin Exp Invest 2014; 5 (1): 137-144

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Heparin-induced thrombocytopenia (HIT) is a rare but serious prothrombotic adverse effect of heparin treatment.
📊
Key Findings & Data:It is induced by platelet-activating antibodies against complexes of platelet factor 4 and heparin.
💡
Conclusion & Impact:J Clin Exp Invest 2014; 5 (1): 137-144
🔬Design:Review & Systematic Survey
📍Scope:2014 Verileri
⚙️Variables:Heparin · trombositopeni · kardiyak cerrahi

Abstract

Heparin-induced thrombocytopenia (HIT) is a rare but serious prothrombotic adverse effect of heparin treatment. It is induced by platelet-activating antibodies against complexes of platelet factor 4 and heparin. Diagnosis rests on a clinical assessment of disease probability and laboratory testing. Prompt diagnosis of HIT, discontinuation of heparin use, and subsequent treatment with alternative anticoagulant drugs are essential steps to prevent serious complications such as thrombus formation, limb amputation, and death. In this review, we describe the clinical features of HIT and to summarize the data available for its management. J Clin Exp Invest 2014; 5 (1): 137-144

Özet

Heparine bağlı trombositopeni (HBT) heparin tedavisinin nadir fakat ciddi bir protrombotik yan etkisidir. Bu durum platelet faktör 4 ve heparin komplekslerine karşı trombosit aktive edici antikorlar tarafından indüklenir. Tanı hastalık olasılığının klinik değerlendirmesi ve laboratuvar testlerine dayanmaktadır. Erken tanı, heparin kullanımının kesilmesi ve müteakiben alternatif antikoagülan ilaçlar ile tedavi trombüs oluşumu, ekstremite amputasyonu ve ölüm gibi ciddi komplikasyonların önlenmesi için önemli adımlardır. Bu derlemede, HBT\'nin klinik özelliklerini tanımlamak ve onun yönetimi için mevcut verileri özetlemeyi amaçladık.

🔖

Cite This Article

Nazli, Y., Çolak, N., Colak, S., Çakır, Ö. (2014). Heparin induced thrombocytopenia. Journal of Clinical and Experimental Investigations, Cilt: 5 Sayı: 1, 137–144. https://doi.org/10.5799/ahinjs.01.2014.01.0379

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Hammon JW, Hines MH. Cardiac Surgery in the Adult. In: Cohn LH, ed. Extracorporeal circulation. New York: McGraw-Hill Press, 2012:283-329.
  2. Shore-lesserson L, Enriquezn LJ. Kaplan’s Cardiac Anesthesia. In: Kaplan JA, Reich DL, Savino JS, ed.